[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349273-105":59,"doc-detail-349273-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","extracellular-vesicle-delivery-of-myricetin-suppresses-ovarian-cancer-through-mitochondrial-dynamics-downregulating-the-ecm1nf-btgf-signaling-pathway","Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics - downregulating the ECM1/NF-κB/TGFβ signaling pathway","","Extracellular matrix protein 1 (ECM1) is linked to EMT and metastasis in multiple cancers, yet its role in mitochondrial dynamics within ovarian cancer remains unclear. Myricetin (MYR), a flavonoid with effects on proliferation and inflammation, is assessed here as cargo delivered by CHO cell–derived extracellular vesicles (CE). CE+MYR reduces OVCAR3 viability, alters morphology and migration, and lowers mitochondrial membrane potential while increasing apoptosis. Mechanistically, CE+MYR downregulates ECM1, NF-κB, and TGFβ, elevates PTEN, p53, and caspases, inhibits mitochondrial fission, and promotes mitochondrial fusion.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extracellular-vesicle-delivery-of-myricetin-suppresses-ovarian-cancer-through-mitochondrial-dynamics-downregulating-the-ecm1nf-btgf-signaling-pathway/349273/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extracellular-vesicle-delivery-of-myricetin-suppresses-ovarian-cancer-through-mitochondrial-dynamics-downregulating-the-ecm1nf-btgf-signaling-pathway/349273.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What delivery system was used to administer myricetin (MYR)?","Question",{"text":113,"@type":114},"CHO cell–derived extracellular vesicles (CE) were used to formulate MYR-loaded extracellular vesicles (CE+MYR) for delivery to ovarian tumor cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did CE+MYR affect ovarian cancer cell viability and morphology?",{"text":118,"@type":114},"CE+MYR reduced OVCAR3 cell viability and caused changes including altered cell morphology, nuclear fragmentation, decreased migration, and reduced mitochondrial membrane potential.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular and mitochondrial processes did CE+MYR regulate?",{"text":122,"@type":114},"CE+MYR decreased ECM1, NF-κB, and TGFβ expression while increasing PTEN, p53, and caspases, and it inhibited mitochondrial fission (DRP1/FIS1) while promoting mitochondrial fusion (MFN1/MFN2).","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349273,1790796829,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nExtracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics by downregulating the ECM1/NF-κB/TGFβ signaling pathway  \nKaumudi Pande1,3, Sridevi Annapurna Singh2,3 & Anbarasu Kannan1,3􀀍  \nOvarian cancer is classified as a female malignancy commonly known as a silent killer with no  \nearly detection symptoms. Extracellular matrix protein 1 (ECM1) is associated with the Epithelialmesenchymal transition (EMT) and metastasis process in different cancers. However, the function of ECM1 in mitochondrial dynamics in ovarian cancer is yet to be determined. Myricetin (MYR) is aflavonoid with medicinal impact on cell proliferation, inflammation, and metastasis. The role of MYR in influencing ECM1 levels to counter ovarian cancer remains unexplored. Chinese hamster ovary (CHO) cells are known to produce protein-based biotherapeutics for various diseases; here, CHO cell-derived extracellular vesicles (CE) can serve as a delivery vehicle of MYR in translational medicine. The current research focused on developing a Myricetin-loaded CHO cell-derived extracellular vesicles (CE + MYR) formulation to facilitate efficient delivery of MYR to target OVCAR3 tumor cells, thereby affecting the ECM1 signaling mechanism. An investigation was carried out to assess the cytotoxic effects of CE + MYR on ovarian cells using an MTT assay to compare the viability of normal CHO cells and the tumor OVCAR3 cells. A decrease in the viability of OVCAR3 cells was observed at IC50 42 µM with MYR treatment and at 30 µMwith CE+ MYR treatment, indicating the efficiency ofCE in delivering MYR; nonetheless, CHO cells remained unaffected at these concentrations. There was an alteration in cell morphology, nuclear fragmentation, decreased migration, and lower mitochondrial membrane potential in the OVCAR3 cells, whereas the CHO cells remained unaffected. There were more apoptotic cells in tumor-treated cells. CE + MYR reduces the expression of ECM1, NF-κB, and TGFβ, whereas the expression of PTEN, p53, and caspases was enhanced. Myricetin inhibited mitochondrial fission (DRP1 and FIS1) and favored mitochondrial fusion (MFN1 and MFN2) . Encapsulating myricetin inCE enhanced antitumor efficacy against ovarian cancer by suppressing proliferation and mitochondrial fission, thereby promoting mitochondrial fusion and apoptosis.  \nKeywords Ovarian cancer, Myricetin, CHO cell-derived extracellular vesicles, Mitochondrial fission, Mitochondrial fusion  \nAbbreviations  \nECM1 Extracellular matrix protein 1  \nEVs Extracellular vesicles  \nMYR Myricetin  \nCHO Chinese hamster ovary  \nCE CHO cell-derived extracellular vesicles  \n1Cancer and Exosome Biology Laboratory, Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysuru 570020, India. 2Department of Traditional Foods & Applied Nutrition, CSIR- Central Food Technological Research Institute, Mysuru 570020, India. 3Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. 􀀍 email: [anbarasu@cftri.res.in](anbarasu@cftri.res.in)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nDiO + CECE + MYRDLSICAM-1 SEM  \nFTIR  \nPBS NF-κBRELA  \nTGFβ  \nPTEN  \nDRP1  \nFIS1  \nMFN1  \nMFN2  \nBID GAPDH  \nDiO labeled CE  \nMyricetin-loaded CHO cell-derived extracellular vesicles Dynamic light scattering  \nIntercellular adhesion molecule 1  \nScanning electron microscopy  \nFourier transform Infrared spectroscopy Phosphate buffer saline  \nNuclear factor kappa-light-chain-enhancer of activated B cells  \nREL-associated protein Transforming growth factor beta Phosphatase and tensin homolog Dynamin-related protein Fission 1  \nMitofusin 1  \nMitofusin 2  \nBH3 interacting-domain death agonist Glyceraldehyde-3-phosphate dehydrogenase  \nOvarian cancer is a precarious neoplasm affecting the female reproductive region and has been examined asa menace to their well-being. It is co","cbCaih1Tb9frIWLP","https://ap.wps.com/l/cbCaih1Tb9frIWLP","pdf",6043084,"English","# Abstract\n## Rationale and Background\n## Objectives and Formulation Strategy\n## Experimental Approach and Outcomes\n## Mechanistic Signaling and Mitochondrial Dynamics","[{\"question\":\"What delivery system was used to administer myricetin (MYR)?\",\"answer\":\"CHO cell–derived extracellular vesicles (CE) were used to formulate MYR-loaded extracellular vesicles (CE+MYR) for delivery to ovarian tumor cells.\"},{\"question\":\"How did CE+MYR affect ovarian cancer cell viability and morphology?\",\"answer\":\"CE+MYR reduced OVCAR3 cell viability and caused changes including altered cell morphology, nuclear fragmentation, decreased migration, and reduced mitochondrial membrane potential.\"},{\"question\":\"Which molecular and mitochondrial processes did CE+MYR regulate?\",\"answer\":\"CE+MYR decreased ECM1, NF-κB, and TGFβ expression while increasing PTEN, p53, and caspases, and it inhibited mitochondrial fission (DRP1/FIS1) while promoting mitochondrial fusion (MFN1/MFN2).\"}]","Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics - downregulating the ECM1/NF-κB/TGFβ signaling pathway | PDF",1790082550,48,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/478ad765eb20bfe8b3ca650812764ae8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/654544fb18e178fb15f8eb452d12bf1d.webp",982,1290]